More on the Limitations of the Activated Partial Thromboplastin Time for Monitoring Argatroban Therapy. 2017

Susan Guy, and Joost Van Veen, and Steve Kitchen
Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom.

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010875 Pipecolic Acids Acids, Pipecolic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias

Related Publications

Susan Guy, and Joost Van Veen, and Steve Kitchen
March 1971, Canadian Medical Association journal,
Susan Guy, and Joost Van Veen, and Steve Kitchen
January 2010, Acta anaesthesiologica Scandinavica,
Susan Guy, and Joost Van Veen, and Steve Kitchen
May 1980, World journal of surgery,
Susan Guy, and Joost Van Veen, and Steve Kitchen
September 2017, Seminars in thrombosis and hemostasis,
Susan Guy, and Joost Van Veen, and Steve Kitchen
January 2001, American journal of clinical pathology,
Susan Guy, and Joost Van Veen, and Steve Kitchen
June 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Susan Guy, and Joost Van Veen, and Steve Kitchen
May 1994, Catheterization and cardiovascular diagnosis,
Susan Guy, and Joost Van Veen, and Steve Kitchen
October 1995, The Annals of pharmacotherapy,
Susan Guy, and Joost Van Veen, and Steve Kitchen
January 1981, Journal of clinical pathology,
Copied contents to your clipboard!